| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/03/2011 | WO2011013830A1 Organic electroluminescent element |
| 02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 02/03/2011 | WO2011013681A1 Charge transport material and organic electroluminescent element |
| 02/03/2011 | WO2011012674A1 Dihydrobenzoindazoles |
| 02/03/2011 | WO2011012630A1 Substituted bis-aryl pyrazole amides having terminal primary amide functionalization for treating retroviral diseases |
| 02/03/2011 | WO2011012592A1 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | US20110028502 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028490 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake in-hibitors |
| 02/03/2011 | US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders |
| 02/03/2011 | US20110028486 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028484 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028481 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028476 Proton pump inhibitors |
| 02/03/2011 | US20110028474 Protein kinase and phosphatase inhibitors |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028454 Deuterium-enriched bazedoxifene |
| 02/03/2011 | US20110028451 Dihydrobenzoindazoles |
| 02/03/2011 | US20110028447 Indazole derivatives |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 02/03/2011 | US20110028433 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 02/03/2011 | US20110028364 Friction modifier and transmission oil |
| 02/03/2011 | US20110028318 Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas |
| 02/03/2011 | US20110027227 Antiviral drugs for treatment of arenavirus infection |
| 02/03/2011 | US20110023754 Isometric isoindoline yellow pigment |
| 02/03/2011 | CA2768904A1 Dihydrobenzoindazoles |
| 02/03/2011 | CA2768396A1 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | CA2768290A1 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/03/2011 | CA2766515A1 Compounds for the reduction of .beta.-amyloid production |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279185A1 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
| 02/02/2011 | EP2279179A2 Phenyl piperazine compounds, pharmaceutical composition including the same, and use thereof |
| 02/02/2011 | EP2279177A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/02/2011 | EP2279176A1 Novel imidazole derivatives having microbiocidal activity |
| 02/02/2011 | EP2089369B1 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 02/02/2011 | EP1664092B1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 02/02/2011 | EP1606265B1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/02/2011 | CN101965343A 2-aza-bicyclo[2.2.1]heptane derivatives |
| 02/02/2011 | CN101965342A Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
| 02/02/2011 | CN101965338A Novel heterocycles |
| 02/02/2011 | CN101962369A Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 02/02/2011 | CN101962365A Aminoindazole derivatives as protein-kinase inhibitors |
| 02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 02/01/2011 | US7880014 Angiotensin II receptor antagonists |
| 02/01/2011 | US7880009 Cinnamide compound |
| 02/01/2011 | US7880002 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 02/01/2011 | US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis |
| 02/01/2011 | US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879851 Viral polymerase inhibitors |
| 02/01/2011 | US7879838 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 02/01/2011 | CA2630040C Heterocycle-substituted 3-alkyl azetidine derivatives |
| 02/01/2011 | CA2555633C Non-nucleoside reverse transcriptase inhibitors |
| 02/01/2011 | CA2551529C Amide derivative and medicine |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2315713C Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 01/27/2011 | WO2011010840A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2011010839A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/27/2011 | WO2011009845A1 Pyridone glucokinase activators |
| 01/27/2011 | WO2011009484A1 Arylpyrazoles and arylisoxazoles and their use as pkd modulators |
| 01/27/2011 | WO2010143803A3 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same |
| 01/27/2011 | WO2010140139A3 Crystalline forms of 6-(1h- imadazol- 1-yl) -2-phenylquinazoline |
| 01/27/2011 | WO2010118063A3 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use |
| 01/27/2011 | WO2010096426A3 Compounds, compositions, methods of synthesis, and methods of treatment |
| 01/27/2011 | WO2010088518A3 Heterocyclic modulators of gpr119 for treatment of disease |
| 01/27/2011 | US20110021775 Bent allenes, and their metal complexes |
| 01/27/2011 | US20110021631 Method of preparing stabilized pharmaceutical compositions comprising active ingredients susceptible to conversion to alternate polymorph forms |
| 01/27/2011 | US20110021590 Aminopyrrolidinone derivatives and uses thereof |
| 01/27/2011 | US20110021565 Piperidine derivatives as nk3 antagonists |
| 01/27/2011 | US20110021547 Substantially Pure and a Stable Crystalline Form of Bosentan |
| 01/27/2011 | US20110021539 Pyrazinylpyrazoles |
| 01/27/2011 | US20110021538 Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| 01/27/2011 | US20110021537 Heterocyclic pyrazole-carboxamidesas p2y12 antagonists |
| 01/27/2011 | US20110021533 Cysteine prodrugs to treat schizophrenia and drug addiction |
| 01/27/2011 | US20110021532 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/27/2011 | US20110021521 Fused heterocyclic compounds as ion channel modulators |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021492 Pyridazine derivatives as factor xia inhibitors |
| 01/27/2011 | US20110021488 New Compounds |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110017908 Dicationic liquid salts and methods of use thereof |
| 01/27/2011 | US20110016642 Dye composition comprising at least one colorless disulfide/thiol precursor, and dyeing process using the composition |
| 01/27/2011 | CA2768832A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators |
| 01/27/2011 | CA2766522A1 Pyridone glucokinase activators |
| 01/26/2011 | EP2277877A1 Quinazoline derivatives as kinase inhibitors |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277869A1 Cycloalkylamidbenzoxa(thia)zoles as fungicides |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors |
| 01/26/2011 | EP2277862A2 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof |
| 01/26/2011 | EP2277858A1 Amide compound |
| 01/26/2011 | EP2276756A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/26/2011 | EP2276750A2 Substituted pyrimidines and triazines and their use in cancer therapy |
| 01/26/2011 | EP2276747A1 Sulfonamides as zap-70 inhibitors |